Clinical features of Brugada syndrome
Wataru Shimizu, MD, PhD
Journal of Arrhythmia · 2013
doi:10.1016/j.joa.2013.01.009 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Brugada syndrome is a clinical entity characterized by type-1 (coved) ST-segment elevation in the right precordial electrocardiographic leads (V1–V3) and an aborted sudden cardiac death due to ventricular fibrillation (VF) in the absence of structural heart disease. Since 1992, when Brugada and Brugada reported the first case, numerous studies across the world have characterized the clinical, electrocardiographic, electrophysiologic, and prognostic features of Brugada syndrome. Several multicenter studies also suggested the natural history and proposed the risk stratification for subsequent cardiac events. In this review article, the clinical features of Brugada syndrome will be updated.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.